The Walking Wounded: Emerging Treatments for PTSD

Current Psychiatry Reports
Durga BesthaJames Rachal

Abstract

We review the published literature over the last 24 months in the treatment of PTSD for our military men and women. We examined the updated clinical practice guidelines published in June 2017 by the Veteran's administration and Department of Defense and contrasted the guidelines with the most recent literature. We also discuss new directions in PTSD research. Psychotherapy remains one of the most effective treatments for PTSD; unfortunately, few participants remain in treatment to completion. Many of the emerging therapies target NMDA receptor antagonists, cannabinoid receptor modulators, glucocorticoid receptor agonists, non-SSRI antidepressants, and opioid receptor agonists. The newer therapies fall into the drug classes of anti-hypertensives, glutamate modulators, oxytocin, and medication targeting insomnia/hyperarousal. PTSD symptoms are often chronic in our veteran population. While current treatments are helpful, there are often significant residual symptoms. We reviewed the most recent improvements in treatment and discuss therapies that are in the research phase.

References

Aug 3, 2011·Psychiatric Services : a Journal of the American Psychiatric Association·Mary W LuSteven K Dobscha
Jan 8, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Saskia Bj KochMiranda Olff
Feb 9, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ralph J KoekAndrew Leuchter
Apr 8, 2016·Evidence-based Mental Health·Jaclyn SchwartzDan V Iosifescu
Jun 2, 2016·The Journal of Clinical Psychiatry·Christopher RodgmanThomas F Newton
Nov 1, 2016·Social Cognitive and Affective Neuroscience·Laura NawijnMiranda Olff
Nov 12, 2016·Expert Review of Clinical Pharmacology·Eileen Thomas, Dan J Stein
Nov 13, 2016·European Journal of Psychotraumatology·Benjamin KelmendiJohn H Krystal
Dec 4, 2016·Neuroscience Letters·Marin KautzJames W Murrough
Dec 6, 2016·Neuroscience Letters·Lynnette A AverillChadi G Abdallah
Feb 22, 2017·Neuroscience Letters·Ann M RasmussonGraziano Pinna
Mar 9, 2017·Psycho-oncology
Apr 11, 2017·Cyberpsychology, Behavior and Social Networking·Robert N McLayScott Johnston
Jul 2, 2017·Psychopharmacology·Ann M RasmussonMurray B Stein
Jul 12, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Cathaleen MadsenTracey Pérez Koehlmoos
Aug 17, 2017·Current Opinion in Psychology·Mallory Je LoflinMarcel O Bonn-Miller
Aug 28, 2017·Current Psychiatry Reports·John H KrystalRonald S Duman
Sep 19, 2017·Current Psychiatry Reports·Matthew C MishkindGreg M Reger
Nov 5, 2017·Clinical Psychology Review·Autumn M GallegosKathi L Heffner
Dec 1, 2017·The International Journal of Neuropsychopharmacology·Sehrish SayedJames W Murrough
Jan 25, 2018·Brain Sciences·Angelo LavanoGiorgio Volpentesta
Feb 8, 2018·The New England Journal of Medicine·Murray A RaskindGrant D Huang
Jan 1, 2018·Focus : Journal of Life Long Learning in Psychiatry·Anne RichardsThomas Coogan Neylan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Related Papers

Frontiers in Behavioral Neuroscience
Laura E WatkinsBarbara O Rothbaum
The American Journal of Psychiatry
J B FrankE L Giller
Military Psychology : the Official Journal of the Division of Military Psychology, American Psychological Association
Hannah E BergmanNorah C Feeny
Psychiatric Services : a Journal of the American Psychiatric Association
Thad E AbramsMatthew J Friedman
© 2022 Meta ULC. All rights reserved